Free Trial

Charles Schwab Investment Management Inc. Sells 192,487 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

Nu Skin Enterprises logo with Consumer Staples background
Remove Ads

Charles Schwab Investment Management Inc. reduced its holdings in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 21.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 715,577 shares of the company's stock after selling 192,487 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.44% of Nu Skin Enterprises worth $4,930,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in NUS. SBI Securities Co. Ltd. bought a new position in Nu Skin Enterprises during the fourth quarter worth $157,000. US Bancorp DE grew its position in Nu Skin Enterprises by 424.2% in the 4th quarter. US Bancorp DE now owns 7,460 shares of the company's stock worth $51,000 after purchasing an additional 6,037 shares during the last quarter. Proficio Capital Partners LLC bought a new position in shares of Nu Skin Enterprises during the 4th quarter worth about $115,000. Bank of New York Mellon Corp increased its holdings in shares of Nu Skin Enterprises by 18.5% during the 4th quarter. Bank of New York Mellon Corp now owns 613,330 shares of the company's stock worth $4,226,000 after purchasing an additional 95,938 shares during the period. Finally, Rhumbline Advisers raised its position in shares of Nu Skin Enterprises by 70.9% during the fourth quarter. Rhumbline Advisers now owns 138,477 shares of the company's stock valued at $954,000 after buying an additional 57,443 shares during the last quarter. 82.84% of the stock is currently owned by institutional investors.

Nu Skin Enterprises Trading Down 4.2 %

NYSE:NUS traded down $0.31 during trading hours on Friday, hitting $7.20. The stock had a trading volume of 313,950 shares, compared to its average volume of 825,663. The business's 50 day moving average is $7.37 and its 200-day moving average is $7.09. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82. The company has a market cap of $357.86 million, a price-to-earnings ratio of -2.44 and a beta of 1.06. Nu Skin Enterprises, Inc. has a one year low of $5.95 and a one year high of $14.00.

Remove Ads

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.24 by $0.14. The business had revenue of $445.55 million during the quarter, compared to the consensus estimate of $441.10 million. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. Sell-side analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were issued a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a yield of 3.33%. The ex-dividend date of this dividend was Monday, February 24th. Nu Skin Enterprises's payout ratio is -8.14%.

Analyst Ratings Changes

NUS has been the topic of a number of recent research reports. StockNews.com raised Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Tuesday, February 25th. DA Davidson lowered their price objective on Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating on the stock in a research report on Friday, December 20th.

View Our Latest Analysis on Nu Skin Enterprises

About Nu Skin Enterprises

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Recommended Stories

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Should You Invest $1,000 in Nu Skin Enterprises Right Now?

Before you consider Nu Skin Enterprises, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.

While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads